Pegfilgrastim: a new therapy to prevent neutropenic fever.
Bence
Aimee K
AK
College of Pharmacy, University of Kentucky, Lexington, USA.
Adams
Val R
VR
D000970:Antineoplastic Agents / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005334:Fever / Q000209:etiology / Q000517:prevention & control*; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006801:Humans; D009503:Neutropenia / Q000209:etiology / Q000517:prevention & control*; D011092:Polyethylene Glycols; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; C455861:pegfilgrastim; D011092:Polyethylene Glycols; D000069585:Filgrastim